SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (3954)1/16/1998 5:59:00 PM
From: Pseudo Biologist  Read Replies (1) of 9719
 
I think this is all Andy's fault for discussing the Broncos on the biotech threads. And this also should teach PB not to mix patents and football in the same message.

Regardless of the anemia, some VD pseudo favorites like MLNM and BGEN are beginning to show some signs of life.

This is how the major indeces plus Semis and biotech have done since
the close of 97 (98.04% means down 1.96%, etc):
98.04% dow
99.52% nasdaq
99.08% sp500
98.05% WilSmCap
98.93% SOX
99.10% BTK

BTK, the Amex biotech index I much prefer, is actually beating the dow and the S&P500 by a magnificent number of basis points -g-

IXB is market cap-weighted, I think, which makes it a proxy for a handful of the very big bio's: Amgen, Immunex, Genzyme, etc. BTK is dollar weighted and reshuffled every quarter or so; it includes 15-20 companies with representatives of several market cap ranges. The Amex web page has a complete list of components.

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext